Advocate-BREAST80+: A Comprehensive Patient and Advocate-Led Study to Enhance Breast Cancer Care Delivery and Patient-Centered Research in Women aged ≥ 80 years

• DOI: 10.20944/preprints202406.1004.v1
• Publication Date: 2024-06-17T09:05:08Z
• Authors: Ciara C O'Sullivan; Robert A Vierkant; Nicole L Larson; Mary Lou Smith; Cynthia Chauhan; Fergus J Couch; Janet E Olson; Stacy D'Andre; Aminah Jatoi; Kathryn J Ruddy

Background: There are limited evidence-based data to guide treatment recommendations for breast cancer (BC) patients ≥ 80 years (P80+). Identifying and addressing unmet needs are critical. Aims: Advocate-BREAST80+ compared the needs of P80+ vs. patients < 80 years (P80-). Methods: In 12/2021, a REDCap survey was circulated electronically to 6,918 persons enrolled in the Mayo Clinic Breast Disease Registry. The survey asked about concerns and satisfaction with multiple aspects of BC care. Results: 2,437 participants responded (35 % response rate); 202 (8.3%) were P80+. P80+ were less likely to undergo local regional and systemic therapies vs. P80- (p